$28.95-0.89 (-2.98%)
ManpowerGroup Inc.
ManpowerGroup Inc. in the Industrials sector is trading at $28.95. The stock is currently near its 52-week low of $25.15, remaining 10.3% below its 200-day moving average. Technical signals show neutral RSI of 35 and bearish MACD signal, explaining why MAN maintains its current current market pressure. The Whystock Score of 35/100 signals elevated caution as indicators diverge.
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
ManpowerGroup Inc. provides workforce solutions and services under the Manpower, the Experis, and the Talent Solutions brands in the Americas, Southern Europe, Northern Europe, and the Asia Pacific/the Middle East. The company offers recruitment serv...
ManpowerGroup (MAN) is back in focus after a busy start to 2026, with Q1 revenue growth of 10.3%, shareholder-approved equity and governance changes, and the completed sale of its Jefferson Wells U.S. business. See our latest analysis for ManpowerGroup. The recent governance changes, dividend declaration and the Jefferson Wells sale come at a time when ManpowerGroup’s share price has shown a 7.6% 30 day share price return but a 23.3% decline in 1 year total shareholder return. This suggests...
XRX tops Q1 estimates with strong revenue growth and narrower loss, sending shares up 15.6% despite ongoing long-term stock pressure.
FCN misses Q2 EPS estimates despite revenue growth, sending shares down 6.3% as mixed segment performance and margin pressure weigh.
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout. Benzinga readers can review the latest analyst takes on their favorite stocks by visiting Analyst Stock Ratings page. Traders can sort through Benzinga's extensive database of analyst ratings, including by analyst accuracy. Below are the ratings of the most accurate analysts for th
The deal is expected to bolster Sikich’s presence in healthcare, life sciences, and manufacturing and distribution.